BPI has multipurpose industrial operation sites accommodating the pharmaceutical, biopharmaceutical and medical devices manufacturing facilities


Cytotoxic Production Unit

Benta has developed a state-of-the-art manufacturing facility for the production of cytotxic oral solid dosages, to meet the demand for anti-cancer products.


The fully segregated manufacturing suites are strictly designed as per the current Good Manufacturing Practices (cGMP) and the International guidelines to protect the personnel, the environment and to eliminate any risk of contamination.


§  High Level  Containment Compliant Manufacturing Suites

§  Isolator Technology

§  Advanced HVAC System

§  Dedicated Air Handling System and HEPA Filtration

§  State-of -the -art Closed System Equipment

§  Specialized Quality Control Laboratories